REMOVAB
REMOVAB
Discontinued
DIN Number
02385732
Drug Class
Human
Market Date
N/A
Company
HC
fresenius biotech gmbh
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02385732
AIG Number0153159001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FX03 CATUMAXOMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntraperitoneal
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CATUMAXOMABActive
Strength: 0.1 MG / ML
Monograph: CATUMAXOMAB